Physician profile
Stuart D Patterson
NPI 1215931753
$2,965.18
in general payments reported to CMS, 2019-2025
9 companies · $1,335 in 2025
The $1,335 reported for 2025 was more than what 77% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $18.37 · 2021: $253 · 2022: $25.03 · 2023: $80.29 · 2024: $1,108 · 2025: $1,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,835 · Travel and Lodging: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,835.04 |
| Travel and Lodging | $688.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonex Health, INC. | $2,228.72 | 2024-2025 | Sx-One Microknife |
| Stryker Corporation | $243.76 | 2021-2025 | Blueprint Patient Specific Instrumentation, Aequalis Flex Revive, Simpliciti |
| Mvp Orthopedics INC | $172.76 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $164.13 | 2019-2023 | Xiaflex |
| Arthrex, INC. | $72.27 | 2025 | |
| Catalyst Orthoscience | $31.75 | 2021 | |
| Integra Lifesciences Corporation | $20.63 | 2019 | |
| Endo USA, INC. | $18.13 | 2024 | Xiaflex |
| Boston Scientific Corporation | $13.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.